(Q47587084)

4 February 2018

title

DNA immunization with plasmids expressing hCGbeta-chimeras (English)

1 reference

4 February 2018

0 references

1

1 reference

4 February 2018

author name string

Sólveig Hannesdóttir

series ordinal

2

1 reference

4 February 2018

Peter J Delves

series ordinal

3

1 reference

4 February 2018

Torben Lund

series ordinal

4

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 June 2004

1 reference

4 February 2018

published in

Vaccine

1 reference

4 February 2018

volume

22

1 reference

4 February 2018

issue

17-18

1 reference

4 February 2018

page(s)

2146-2153

1 reference

4 February 2018

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.002

1 reference

Ectopic Production of Human Chorionic Gonadotrophin by Neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.002

Ectopic production of human chorionic gonadotropin in malignant tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.002

Have we found the "definitive cancer biomarker"? The diagnostic and therapeutic implications of human chorionic gonadotropin-beta expression as a key to malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.002

Human chorionic gonadotropin-beta subunit gene expression in cultured human fetal and cancer cells of different types and origins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.002

The effects of beta-human chorionic gonadotrophin on the in vitro growth of bladder cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.002

A vaccine that prevents pregnancy in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.002

Epitopes of human chorionic gonadotropin and their relationship to immunogenicity and cross-reactivity of beta-chain mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.002

DNA vaccination favours memory rather than effector B cell responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.002

Identification and selective destruction of shared epitopes in human chorionic gonadotropin beta subunit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.002

Refocusing of B-cell responses following a single amino acid substitution in an antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.002

C3d of complement as a molecular adjuvant: bridging innate and acquired immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.002

Electropermeabilization of skeletal muscle enhances gene transfer in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.002

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.002

C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.002

Nucleic acid vaccination against virally induced tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.002

Overcoming the poor immunogenicity of a protein by DNA immunization as a fusion construct

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.002

Increased DNA vaccine delivery and immunogenicity by electroporation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.002

Enhanced molecular mimicry of CEA using photoaffinity crosslinked C3d peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.002

C3d enhancement of neutralizing antibodies to measles hemagglutinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.002

Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.002

Fusion of C3d molecule with bovine rotavirus VP7 or bovine herpesvirus type 1 glycoprotein D inhibits immune responses following DNA immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.002

10.1016/J.VACCINE.2003.12.002

7 January 2021

Identifiers

DOI

1 reference

4 February 2018

release_yut6yrhyd5drvbqmzkxuejipba

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yut6yrhyd5drvbqmzkxuejipba

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

4 February 2018